Global Transplant Market Forecast 2019-2029 : Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users

移植の世界市場2019-2029:組織製品、免疫抑制薬、保存液、組織移植、臓器移植、心臓弁、血管移植片、骨移植片、角膜、皮膚移植片、骨髄、その他の組織、腎臓移植、肝臓移植、心臓移植、肺移植、膵臓移植、その他の移植、病院、移植センター、その他のエンドユーザー

◆タイトル:Global Transplant Market Forecast 2019-2029 : Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users
◆商品コード:VGN902099
◆調査・発行会社:visiongain
◆発行日:2018年12月
◆ページ数:184
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Sigle UserGBP3,499 ⇒換算¥475,864見積依頼/購入/質問フォーム
Departmental/Five UserGBP3,899 ⇒換算¥530,264見積依頼/購入/質問フォーム
Site LicenseGBP4,999 ⇒換算¥679,864見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"移植の世界市場2019-2029:組織製品、免疫抑制薬、保存液、組織移植、臓器移植、心臓弁、血管移植片、骨移植片、角膜、皮膚移植片、骨髄、その他の組織、腎臓移植、肝臓移植、心臓移植、肺移植、膵臓移植、その他の移植、病院、移植センター、その他のエンドユーザー"について調査・分析し、レポートサマリー、世界市場規模・市場予測、地域別市場分析、種類別分析、用途別分析、市場環境分析、主要企業分析などの情報をお届けいたします。

The global transplant market will reach $29bn in 2019 and is estimated to grow at a CAGR of 9.9% from 2018- 2029. Visiongain estimated that Germany will hold 7.3% of the global transplant market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 184-page report you will receive 82 tables and 55 figures– all unavailable elsewhere.

The 184-page report provides clear detailed insight into the transplant market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Transplant Market from 2019-2029

• Forecast of the Global Transplant market by Product:
• Tissue Products
• Immunosuppressive Drugs
• Preservation Solutions

• Forecast of the Global Transplant market by Application:
• Tissue Transplant: Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues
• Organ Transplant: Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant

• Forecast of the Global Transplant market by End-user:
• Hospitals
• Transplant Centers
• Others

• This report provides individual revenue forecasts to 2029 for these regional and national markets:
• North America: US, Canada
• EU: Germany, France, United Kingdom, Italy, Spain and rest of EU
• Asia-Pacific: Japan, China, India and rest of Asia-Pacific
• RoW: Brazil, Mexico, Russia, South Africa and rest of ROW

• Our study discusses the selected leading companies that are the major players in the transplant market:
• AbbVie, Inc.
• Arthrex, Inc.
• Medtronic
• Novartis AG
• Stryker
• Teva Pharmaceuticals
• Veloxis Pharmaceuticals
• Zimmer Biomet

• This study discusses the competitive landscape, including factors that drive and restrain the transplant market

• This report also provides the number organ transplant procedures from 2012-2027 in selected countries:
• The US
• Canada
• Germany
• UK
• France
• Italy
• Spain
• Japan
• China
• Brazil
• Mexico
• South Africa
• Russia

Visiongain’s study is intended for anyone requiring commercial analyses for the transplant market. You find data, trends and prediction

【レポートの目次】

1. Report Overview
1.1 Why You Should Read This Report
1.2 How This Report Delivers
1.3 Key Questions Answered by This Analytical Report Include:
1.4 Who is This Report for?
1.5 Methodology
1.5.1 Primary Research
1.5.2 Secondary Research
1.5.3 Market Evaluation & Forecasting Methodology
1.6 Frequently Asked Questions (FAQ)
1.7 Associated Visiongain Reports
1.8 About Visiongain

2. Introduction to Transplant
2.1 What is Transplant?
2.2 What is Transplantation?
2.3 What is Organ Rejection?
2.4 History of Organ and Tissue Transplant
2.5 Types of Transplant
2.5.1 Autotransplantation
2.5.2 Allotransplantation
2.5.3 . Xenotransplantation
2.6 Risks Associated with Transplantation
2.7 Number of Organ transplant Procedures in Major Countries
2.7.1 U.S.
2.7.2 Canada
2.7.3 Germany
2.7.4 UK
2.7.5 France
2.7.6 Italy
2.7.7 Spain
2.7.8 Japan
2.7.9 China
2.7.10 Brazil
2.7.11 Mexico
2.7.12 South Africa
2.7.13 Russia
2.8 Humanistic and Economic Burden
2.8.1 Morbidity and Mortality
2.8.2 Economic Impact

3. Global Transplant Market Size and Forecast, 2019-2029

4. Global Transplant Market Size and Forecast by Product, 2019-2029
4.1 Tissue Products
4.2 Immunosuppressive Drugs
4.3 Preservation Solutions

5. Global Transplant Market Size and Forecast by Application, 2019-2029
5.1 Tissue Transplant
5.1.1 Heart Valve Replacement
5.1.2 Vascular Grafts Replacement
5.1.3 Bone Grafts Transplantation
5.1.4 Cornea Transplantation
5.1.5 Skin Grafts Transplantation
5.1.6 Bone Marrow Transplantation
5.1.7 Other Tissues Transplant
5.2 Organ transplant
5.2.1 Kidney Transplant
5.2.2 Liver Transplant
5.2.3 Heart Transplant
5.2.4 Lung Transplant
5.2.5 Pancreas Transplant
5.2.6 Other Organ Transplant

6. Global Transplant Market Size and Forecast by End-User, 2019-2029
6.1 Hospitals
6.2 Transplant Centers
6.3 Others

7. Transplant Market Landscape
7.1 Market Drivers
7.1.1 Increased Incidence of Organ Failure
7.1.2 Advances in Technology
7.1.3 Initiatives by Government and NGO’s to Create Awareness for Organ Donation
7.1.4 Increased M&A and Strategic Collaboration
7.1.5 Increased Healthcare Expenditure
7.1.6 Developed Tissue banks
7.1.7 Innovation of 3D Bioprinting
7.2 Market Growth Inhibitors
7.2.1 Transplant Rejection
7.2.2 Intense Competition among Vendors
7.2.3 Shortage of Organ Donors
7.2.4 Ethical and Cultural Issues

8. Global Transplant Market Size and Forecast by Region, 2019-2029
8.1 North America Transplant Market Forecast 2019 – 2029
8.1.1 U.S. Transplant Market Forecast 2019 – 2029
8.1.2 Canada Transplant Market Forecast 2019 – 2029
8.2 Europe Transplant Market Forecast 2019 – 2029
8.2.1 Germany Transplant Market Forecast 2019 – 2029
8.2.2 UK Transplant Market Forecast 2019 – 2029
8.2.3 France Transplant Market Forecast 2019 – 2029
8.2.4 Italy Transplant Market Forecast 2019 – 2029
8.2.5 Spain Transplant Market Forecast 2019 – 2029
8.2.6 Rest of Europe Transplant Market Forecast 2019 – 2029
8.3 Asia-Pacific Transplant Market Forecast 2019 – 2029
8.3.1 Japan Transplant Market Forecast 2019 – 2029
8.3.2 China Transplant Market Forecast 2019 – 2029
8.3.3 India Transplant Market Forecast 2019 – 2029
8.3.4 Rest of Asia-Pacific Transplant Market Forecast 2019 – 2029
8.4 RoW Transplant Market Forecast 2019 – 2029
8.4.1 Brazil Transplant Market Forecast 2019 – 2029
8.4.2 Mexico Transplant Market Forecast 2019 – 2029
8.4.3 Russia Transplant Market Forecast 2019 – 2029
8.4.4 South Africa Transplant Market Forecast 2019 – 2029
8.4.5 Rest of RoW Market Forecast 2019 – 2029

9. Leading Companies in the Global Transplant Market
9.1 Zimmer Biomet
9.1.1 Overview
9.1.2 Leading Products
9.1.3 Recent Developments
9.1.4 SWOT Analysis
9.2 AbbVie Inc.
9.2.1 Overview
9.2.2 Leading Products
9.2.3 Strategic Planning
9.2.4 SWOT Analysis
9.3 Teva Pharmaceuticals
9.3.1 Overview
9.3.2 Leading Products
9.3.3 Recent Developments
9.3.4 SWOT Analysis
9.4 Novartis AG
9.4.1 Overview
9.4.2 Leading Products
9.4.3 Recent Developments
9.4.4 SWOT Analysis
9.5 Medtronic
9.5.1 Overview
9.5.2 Leading Products
9.5.3 Recent Developments
9.5.4 SWOT Analysis
9.6 Arthrex
9.6.1 Overview
9.6.2 Leading Products
9.6.3 Recent Developments
9.6.4 SWOT Analysis
9.7 Stryker Corporation
9.7.1 Overview
9.7.2 Leading Products
9.7.3 Recent Developments
9.7.4 SWOT Analysis
9.8 Veloxis Pharmaceuticals
9.8.1 Overview
9.8.2 Leading Products
9.8.3 Recent Developments
9.8.4 SWOT Analysis

10. Other Prominent Companies

11. Conclusion

Appendices
Associated Reports
Report Sales Order Form
About Visiongain
Report Evaluation Form

List of Tables
Table 2.1. Organ Transplant Procedure Average Cost
Table 3.1. Global Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 4.1 Global Tissue Products Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 4.2 Global Immunosuppressive Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 4.3 Global Preservation Solutions Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.1. Global Tissue Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.2 Global Heart Valve Replacement Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.3 Global Vascular Grafts Replacement Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.4 Global Bone Grafts Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.5 Global Cornea Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.6 Global Skin Grafts Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.7 Global Bone Marrow Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.8 Global Other Tissue Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.9 Global Organ Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.10 Global Kidney Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.11 Global Liver Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.12 Global Heart Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.13 Global Lung Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.14 Global Pancreas Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.15 Global Other Organ Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Figure 6.1 Global Transplant Market Segmentation by End-User
Table 6.1. Global Hospital Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 6.2 Global Transplant Centers Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 6.3 Global Others End Use Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.1 North America Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.2 North America Transplant Market by Product Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.3 North America Transplant Market by Application Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.4 North America Tissue Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.5 North America Organ Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.6 North America Transplant Market by End-User Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.7 U.S. Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.8 Canada Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.9 Europe Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.10 Europe Transplant Market by Product Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.11 Europe Transplant Market by Application Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.12 Europe Tissue Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.13 Europe Organ Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.14 Europe Transplant Market by End-User Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.15 Germany Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.16 UK Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.17 France Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.18 Italy Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.19 Spain Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.20 Rest of Europe Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.21 Asia-Pacific Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.22 Asia-Pacific Transplant Market by Product Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.23 Asia-Pacific Transplant Market by Application Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.24 Asia-Pacific Tissue Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.25 Asia-Pacific Organ Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.26 Asia-Pacific Transplant Market by End-User Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.27 Japan Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.28 China Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.29 India Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.30 Rest of Asia-Pacific Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.31 RoW Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.32 RoW Transplant Market by Product Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.33 RoW Transplant Market by Application Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.34 RoW Tissue Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.35 RoW Organ Transplant Market by Type Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.36 RoW Transplant Market by End-User Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.37 Brazil Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.38 Mexico Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.39 Russia Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.40 South Africa Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 8.41 Rest of RoW Transplant Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 9.1 Zimmer Biomet: Overview
Table 9.2 Zimmer Biomet: Leading Products
Table 9.3 AbbVie Inc.: Overview
Table 9.4 AbbVie Inc.: Leading Products
Table 9.5 Teva Pharmaceuticals: Overview
Table 9.6 Teva Pharmaceuticals: Leading Products
Table 9.7 Novartis AG: Overview 2017
Table 9.8 Novartis AG: Leading Products
Table 9.9: Medtronic: Overview
Table 9.10 Medtronic: Leading Products
Table 9.11 Arthrex: Overview
Table 9.12 Arthrex: Leading Products
Table 9.13 Stryker Corporation: Overview
Table 9.14 Stryker Corporation: Leading Products
Table 9.15 Veloxis Pharmaceuticals: Overview
Table 9.16 Veloxis Pharmaceuticals: Leading Products
Table 10.1 List of Other Prominent Companies in the Transplant Market

List of Figures
Figure 2.1 Types of Transplant
Figure 2.2 Registered diabetes people in England in 2016 by gender
Figure 2.3 Number of Transplant Procedures (2012-2017)
Figure 2.4 Number of Transplant Procedures (2012-2017)
Figure 2.5 Number of Transplant Procedures (2012-2017)
Figure 2.6 Number of Transplant Procedures (2012-2017)
Figure 2.7 Number of Transplant Procedures (2012-2017)
Figure 2.8 Number of Transplant Procedures (2012-2017)
Figure 2.9 Number of Transplant Procedures (2012-2017)
Figure 2.10 Number of Transplant Procedures (2012-2017)
Figure 2.11 Number of Transplant Procedures (2015-2016)
Figure 2.12 Number of Transplant Procedures (2012-2017)
Figure 2.13 Number of Transplant Procedures (2012-2017)
Figure 2.14 Number of Transplant Procedures (2012-2016)
Figure 2.15 Number of Transplant Procedures (2012-2017)
Figure 4.1 Global Transplant Market Segmentation by Product
Figure 5.1 Global Transplant Market Segmentation by Application
Figure 5.2 Global Tissue Transplant Market Segmentation by Type
Figure 5.3 Global Organ Transplant Market Segmentation by Type Revenue (%), 2017-2029
Figure 7.1 Transplant Market Landscape
Figure 8.1 Global Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
Figure 8.2 Global Transplant Market by Regional Breakdown:
Figure 8.3 Global Transplant Market by Regional Market Share (%), 2017
Figure 8.4 Global Transplant Market by Regional Market Share (%), 2023
Figure 8.5 Global Transplant Market by Regional Market Share (%), 2029
Figure 8.6 North America Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
Figure 8.7 North America Transplant Market by Regional Breakdown: Revenue (%), 2017 & 2029
Figure 8.8 North America Transplant Market by Product (% Share): 2017, 2023, & 2029
Figure 8.9 North America Transplant Market by Application (% Share): 2017, 2023, & 2029
Figure 8.10 North America Transplant Market by End-User (% Share): 2017, 2023, & 2029
Figure 8.11 Europe Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
Figure 8.12 Europe Transplant Market by Regional Breakdown: Revenue (%), 2017, 2023, & 2029
Figure 8.13 Europe Transplant Market by Product (% Share), 2017, 2023, & 2029
Figure 8.14 Europe Transplant Market by Application (% Share), 2017, 2023, & 2029
Figure 8.15 Europe Transplant Market by End-User (% Share), 2017, 2023, & 2029
Figure 8.16 Asia-Pacific Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
Figure 8.17 Asia-Pacific Transplant Market by Regional Breakdown: Revenue (%), 2017, 2023, & 2029
Figure 8.18 Asia Pacific Transplant Market by Product (% Share): 2017, 2023, & 2029
Figure 8.19 Asia-Pacific Transplant Market by Application (% Share): 2017, 2023, & 2029
Figure 8.20 Asia-Pacific Transplant Market by End-User (% Share): 2017, 2023, & 2029
Figure 8.21 RoW Transplant Market by Regional Breakdown: Revenue ($bn), 2017-2029
Figure 8.22 RoW Transplant Market by Regional Breakdown: Revenue (%), 2017, 2023, & 2029
Figure 8.23 RoW Transplant Market by Product (% Share): 2017, 2023, & 2029
Figure 8.24 RoW Transplant Market by Application (% Share): 2017, 2023, & 2029
Figure 8.25 RoW Transplant Market by End-User: (% Share), 2017, 2023, & 2029
Figure 9.1 Zimmer Biomet: SWOT Analysis
Figure 9.2 AbbVie Inc.: SWOT Analysis
Figure 9.3 Teva Pharmaceuticals: SWOT Analysis
Figure 9.4 Novartis AG: SWOT Analysis
Figure 9.5 Medtronic: SWOT Analysis
Figure 9.6 Arthrex: SWOT Analysis
Figure 9.7 Stryker: SWOT Analysis
Figure 9.8 Veloxis Pharmaceuticals: SWOT Analysis
Figure 11.1 Global Transplant Market: Market Opportunity by Region (% share) 2017 and 2029
Figure 11.2 Global Transplant Market: Market Opportunity by Application (% share) 2017 and 2029



★調査レポート[移植の世界市場2019-2029:組織製品、免疫抑制薬、保存液、組織移植、臓器移植、心臓弁、血管移植片、骨移植片、角膜、皮膚移植片、骨髄、その他の組織、腎臓移植、肝臓移植、心臓移植、肺移植、膵臓移植、その他の移植、病院、移植センター、その他のエンドユーザー] ( Global Transplant Market Forecast 2019-2029 : Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users / VGN902099) 販売に関する免責事項
[移植の世界市場2019-2029:組織製品、免疫抑制薬、保存液、組織移植、臓器移植、心臓弁、血管移植片、骨移植片、角膜、皮膚移植片、骨髄、その他の組織、腎臓移植、肝臓移植、心臓移植、肺移植、膵臓移植、その他の移植、病院、移植センター、その他のエンドユーザー] ( Global Transplant Market Forecast 2019-2029 : Tissue Products, Immunosuppressive Drugs, Preservation Solutions, Tissue Transplant, Organ Transplant, Heart Valve, Vascular Grafts, Bone Grafts, Cornea, Skin Grafts, Bone Marrow, Other Tissues, Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Pancreas Transplant, Other Transplant, Hospitals, Transplant Centres, Other End-Users / VGN902099) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆